Seok Kyu Oh
Overview
Explore the profile of Seok Kyu Oh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
925
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ko G, Lee J, Boo K, Choi J, Kim S, Joo S, et al.
Ann Geriatr Med Res
. 2025 Feb;
PMID: 39945132
Background: This study aimed to evaluate the long-term clinical outcomes of patients with acute myocardial infarction (AMI) who underwent successful stent implantation and were subsequently treated with angiotensin-converting enzyme inhibitors...
2.
Shin Y, Lee S, Lee S, Kim J, Lim Y, Ahn J, et al.
Medicine (Baltimore)
. 2024 Aug;
103(35):e38483.
PMID: 39213207
Optimal timing of revascularization for patients who presented with non-ST segment elevation myocardial infarction (NSTEMI) and severe left ventricular (LV) dysfunction is unclear. A total of 386 NSTEMI patients with...
3.
Jeong J, Lee K, Park S, Kim S, Kim M, Chae S, et al.
Front Cardiovasc Med
. 2024 Apr;
11:1340022.
PMID: 38646154
Several regression-based models for predicting outcomes after acute myocardial infarction (AMI) have been developed. However, prediction models that encompass diverse patient-related factors over time are limited. This study aimed to...
4.
Park S, Kim D, Lee K, Park M, Chang K, Jeong M, et al.
Sci Rep
. 2024 Mar;
14(1):365.
PMID: 38429290
Body mass index (BMI), as an important risk factor related to metabolic disease. However, in some studies higher BMI was emphasized as a beneficial factor in the clinical course of...
5.
Sim D, Hyun D, Hong Y, Kim J, Ahn Y, Jeong M, et al.
Chonnam Med J
. 2024 Feb;
60(1):78-86.
PMID: 38304131
There are limited data on outcomes after implantation of everolimus-eluting stents (EES) in East Asian patients with small vessel coronary lesions. A total of 1,600 patients treated with XIENCE EES...
6.
Cho J, Joo D, Yun K, Kim B, Hong M, Jang Y, et al.
Front Cardiovasc Med
. 2023 Aug;
10:1237826.
PMID: 37614943
Background: The aim of this study was to evaluate the efficacy and safety of ticagrelor monotherapy in patients with small vessel disease compared with ticagrelor-based DAPT within the Ticagrelor Monotherapy...
7.
Doan K, Liu T, Yun W, Kim Y, Yun K, Oh S, et al.
J Clin Med
. 2023 Jun;
12(12).
PMID: 37373765
Background: Calcified coronary lesions can cause stent under-expansion, malapposition, and polymer degradation, hence increasing the risk of adverse clinical outcomes. Percutaneous coronary intervention (PCI) guided by intravascular ultrasound (IVUS) has...
8.
Cho K, Shin M, Kim M, Sim D, Hong Y, Kim J, et al.
J Am Heart Assoc
. 2023 Jun;
12(13):e029728.
PMID: 37345749
Background Data on the incidence, relevant patient factors, and clinical outcomes of the misdiagnosis of ST-segment-elevation myocardial infarction (STEMI) in the modern era of percutaneous coronary intervention are limited. Methods...
9.
Bae S, Cha J, Lim S, Kim J, Joo H, Park J, et al.
JACC Cardiovasc Interv
. 2023 Jan;
16(1):64-75.
PMID: 36599589
Background: A limitation of the current guidelines regarding the timing of invasive coronary angiography for patients with non-ST-segment elevation acute coronary syndrome is the randomization time. To date, no study...
10.
Choi K, Park Y, Song Y, Park T, Lee J, Yang J, et al.
JAMA Cardiol
. 2022 Sep;
7(11):1100-1108.
PMID: 36169938
Importance: Although P2Y12 inhibitor monotherapy after a minimum period of dual antiplatelet therapy (DAPT) is a well-known way to reduce the risk of bleeding after percutaneous coronary intervention (PCI), data...